You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR NALTREXONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for naltrexone

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000195 ↗	Neurobiology of Opioid Dependence: 4 - 4	Withdrawn	National Institute on Drug Abuse (NIDA)	Phase 2	1993-01-01	The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000195 ↗	Neurobiology of Opioid Dependence: 4 - 4	Withdrawn	Yale University	Phase 2	1993-01-01	The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000196 ↗	Neurobiology of Opioid Dependence: 5 - 5	Withdrawn	National Institute on Drug Abuse (NIDA)	Phase 2	1993-01-01	The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
NCT00000196 ↗	Neurobiology of Opioid Dependence: 5 - 5	Withdrawn	Yale University	Phase 2	1993-01-01	The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for naltrexone

Condition Name

Chart
Table

Condition Name for naltrexone
Intervention	Trials
Alcoholism	55
Alcohol Dependence	50
Obesity	28
Opioid-Related Disorders	20
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for naltrexone
Intervention	Trials
Alcoholism	124
Opioid-Related Disorders	97
Disease	50
Substance-Related Disorders	33
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for naltrexone

Trials by Country

Map
Table

Trials by Country for naltrexone
Location	Trials
United States	816
Canada	15
Germany	13
China	12
Russian Federation	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for naltrexone
Location	Trials
New York	69
Connecticut	58
California	54
Pennsylvania	53
Texas	38
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for naltrexone

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for naltrexone
Clinical Trial Phase	Trials
Phase 4	104
Phase 3	62
Phase 2/Phase 3	36
[disabled in preview]	147
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for naltrexone
Clinical Trial Phase	Trials
Completed	303
Recruiting	58
Not yet recruiting	47
[disabled in preview]	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for naltrexone

Sponsor Name

Chart
Table

Sponsor Name for naltrexone
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	96
National Institute on Alcohol Abuse and Alcoholism (NIAAA)	61
Yale University	39
[disabled in preview]	29
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for naltrexone
Sponsor	Trials
Other	523
NIH	180
Industry	133
[disabled in preview]	25
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.